SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its divestment plan for GRAIL from the European Commission (EC). While this does not mean the method of divestment has been finalized, the company is pleased to reach an agreement with the EC […]
From left : Christoph Niewöhner – Thomas Rosche – Thorsten Greiner – Giovanni Santamaria – David Bassetti In the context of its extensive growth and internationalization strategy, the BASSETTI Group announces the acquisition of the German software provider MAQSIMA. This strategic acquisition is a further chapter in BASSETTI’s dynamic external expansion, which aims to strengthen its market presence […]
Cardiff, UK – BBI Solutions OEM Limited (BBI), the premier independent manufacturer of immunodiagnostic reagents globally, has announced the successful closing of the acquisition of IBEX Technologies Inc. (IBEX), a leading developer and manufacturer of high-precision enzymes and diagnostic solutions located in Montréal, Québec. This acquisition strategically enhances BBI’s capabilities to support In Vitro Diagnostic […]
Valmet has completed the acquisition of the Process Gas Chromatography & Integration business from Siemens AG. The closing of the transaction follows the agreement that was announced on July 17, 2023. The Process Gas Chromatography & Integration business of Siemens AG is a market leader with its MAXUM II Gas Chromatograph platform, Systems Integration, and […]
Merger forms a global leader of FTIR and spectroscopy accessories. Orpington, UK — Specac, Ltd (“Specac”), a portfolio company of Ampersand Capital Partners and leader in the design and manufacture of spectroscopy accessories and sample prep solutions, announced today the acquisition of Harrick Scientific, Inc (“Harrick”), a well-known manufacturer of high-quality spectroscopy equipment and optical […]
EditCo is focused on the development and manufacture of highly optimized CRISPR guide RNA designs and edited cells for the global cell biology and gene therapy research markets REDWOOD CITY, CA – EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego’s engineered cell solutions and enhanced guide RNA business. Borne […]
Leadership change simultaneous to the Eclipse Cell Engineering platform spinout as EditCo Bio REDWOOD CITY, CA – Synthego Corporation, a leading provider of genome engineering solutions, announced that Paul Dabrowski will step down as Chief Executive Officer, effective immediately. Craig Christianson has been appointed Chief Executive Officer following an extensive search process. Mr. Dabrowski, a […]
GLENDALE HEIGHTS, Ill. — Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC (“Biologos”), a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The partnership with Ampersand will include investments to expand Biologos’ […]
Orpington, UK – Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Specac Limited (“Specac”), an industry leader in the design and manufacture of spectroscopy accessories and sample prep solutions. “On behalf of the entire Specac organization, we are excited to […]
Sale of portfolio company, Specac International, to a US Private Equity investor is expected to deliver more than a 10x return The transaction generates approximate gross proceeds of £27 million to Foresight funds, including proceeds received to date Foresight invested in 2015 and helped position Specac as a global leader in mass spectroscopy accessories With […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
